Novartis Sirdalud muscle relaxant

Sirdalud is a prescription muscle relaxant containing the active ingredient Tizanidine, designed to treat muscle spasms and stiffness. The brand was developed by Sandoz, which later became part of the Novartis Group through a historic merger in 1996.

Novartis is a leading global pharmaceutical company headquartered in Basel, Switzerland. While the parent company is Swiss, the manufacturing of Sirdalud occurs in various global facilities depending on the target market. The specific packaging shown identifies Novartis Farma S.p.A. as the marketing authorization holder in Italy, indicating its direct distribution through the company's Italian subsidiary to serve the European market.